// App-Quantinova.ai

e15679 : Molecular profiling by circulating tumor DNA (ctDNA) and benefit from anti-PD-1 in HCC.

Researchers

Presenter

  • Roberto Carmagnani Pestana

Principal Investigators

  • Yehia I. Abugabal

  • Lianchun Xiao

  • Manal Hassan

  • Reham Abdel wahab Hassan

  • Lauren Girard

  • Kanwal Pratap Singh Raghav

  • Jeffrey Morris

  • Asif Rashid

  • Aliya Qayyum

  • Funda Meric-Bernstam

  • Robert A. Wolff

  • James C. Yao

  • Hesham M. Amin

  • Ahmed Omar Kaseb

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Assiut University Hospital, Assiut, Egypt

  • GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alpha-fetoprotein

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved